PT918504E - Utilizacao da genisteina como agente preventivo contra a fotolesao e o cancro cutaneos induzidos pela radiacao ultravioleta - Google Patents

Utilizacao da genisteina como agente preventivo contra a fotolesao e o cancro cutaneos induzidos pela radiacao ultravioleta

Info

Publication number
PT918504E
PT918504E PT97934083T PT97934083T PT918504E PT 918504 E PT918504 E PT 918504E PT 97934083 T PT97934083 T PT 97934083T PT 97934083 T PT97934083 T PT 97934083T PT 918504 E PT918504 E PT 918504E
Authority
PT
Portugal
Prior art keywords
genistein
induced
photolesis
cutaneos
cancer
Prior art date
Application number
PT97934083T
Other languages
English (en)
Inventor
Huachen Wei
Original Assignee
Mount Sinai School Of Med Of T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24639167&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT918504(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mount Sinai School Of Med Of T filed Critical Mount Sinai School Of Med Of T
Publication of PT918504E publication Critical patent/PT918504E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PT97934083T 1996-06-07 1997-06-09 Utilizacao da genisteina como agente preventivo contra a fotolesao e o cancro cutaneos induzidos pela radiacao ultravioleta PT918504E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/657,915 US5824702A (en) 1996-06-07 1996-06-07 Genistein as a preventive against ultraviolet induced skin photodamage and cancer

Publications (1)

Publication Number Publication Date
PT918504E true PT918504E (pt) 2003-08-29

Family

ID=24639167

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97934083T PT918504E (pt) 1996-06-07 1997-06-09 Utilizacao da genisteina como agente preventivo contra a fotolesao e o cancro cutaneos induzidos pela radiacao ultravioleta

Country Status (11)

Country Link
US (1) US5824702A (pt)
EP (1) EP0918504B1 (pt)
JP (1) JP2000511907A (pt)
AT (1) ATE234599T1 (pt)
AU (1) AU716131B2 (pt)
CA (1) CA2257579C (pt)
DE (1) DE69719994T2 (pt)
DK (1) DK0918504T3 (pt)
ES (1) ES2188963T3 (pt)
PT (1) PT918504E (pt)
WO (1) WO1997046208A2 (pt)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN166195A0 (en) 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
US20050058709A1 (en) * 1997-06-04 2005-03-17 Fisher Gary J. Methods for inhibiting photoaging of human skin using orally-administered agent
US6060070A (en) * 1997-06-11 2000-05-09 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of aging skin and wrinkles
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
AUPP112497A0 (en) 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
CA2323364A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Compositions for regulating skin appearance
TWI234455B (en) * 1998-04-02 2005-06-21 Univ Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6683069B1 (en) 1998-04-02 2004-01-27 Regents Of The University Of Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
FR2781154B1 (fr) * 1998-07-15 2001-09-07 Lafon Labor Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
US20040131579A1 (en) * 1998-09-10 2004-07-08 Avon Products, Inc. Method and compositions for reducing dermatological aging and for reducing bruising
DE69932621D1 (de) * 1998-10-09 2006-09-14 Yakult Honsha Kk Hautpflegezubereitungen zur äusseren anwendung
WO2000037072A1 (en) * 1998-12-22 2000-06-29 Alcon Laboratories, Inc. Use of inhibitors of gag synthesis for the treatment of corneal haze
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
JP2001131081A (ja) 1999-11-09 2001-05-15 Shinei Ferumentekku:Kk スーパーオキサイド消去剤および飲料
JP2001131052A (ja) * 1999-11-09 2001-05-15 Shinei Ferumentekku:Kk 化粧品
CA2416796A1 (en) * 2000-06-14 2001-12-20 Alla Shapiro Radioprotective agents
ATE363902T1 (de) * 2000-06-14 2007-06-15 Us Health Isoflavonen gegen strahlungsinduzierte mortalität
EP1767215A1 (en) * 2000-06-14 2007-03-28 The United States of America as represented by The Secretary, Department of Health and Human Services National Institutes of Health Isoflavones against radiation-induced mortality
EP1294349A2 (en) * 2000-06-26 2003-03-26 The Regents Of The University Of Michigan Use of egf-r protein tyrosine kinase inhibitors for preventing photoaging in human skin
FR2815861B1 (fr) * 2000-10-26 2003-02-28 Oreal Utilisation de l'association d'au moins un carotenoide et d'au moins un isoflavonoide pour traiter les signes cutanes du vieillissement
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
FR2820974B1 (fr) * 2001-02-21 2004-02-13 Pharmascience Lab Composition topique comprenant une solution vraie contenant un derive de chromane ou de chromene, son procede de preparation et son utilisation cosmetique et therapeutique
EP1234572B1 (de) 2001-02-26 2013-10-30 Mibelle AG Cosmetics Isoflavon-Aglykone enhaltende Hautbehandlungsmittel
EP1370294A2 (en) 2001-02-27 2003-12-17 The Regents Of The University Of Michigan Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US20020160061A1 (en) * 2001-02-28 2002-10-31 Claude Saliou Use of legume products for the treatment of external aggressions
JP4901025B2 (ja) * 2001-06-22 2012-03-21 株式会社ナリス化粧品 エラスターゼ阻害剤
JP4901024B2 (ja) * 2001-06-22 2012-03-21 株式会社ナリス化粧品 ８−ＯＨｄＧ（８−ハイドロキシデオキシグアノシン）産生抑制剤
EP1321123A1 (de) * 2001-12-20 2003-06-25 Cognis France S.A. Verwendung eines Extraktes der Pflanze Baptisia tinctoria in einer kosmetischen Zusammensetzung
NZ537359A (en) * 2002-06-25 2006-10-27 Cosmeceutic Solutions Pty Ltd Topical cosmetic compositions for transdermal delivery
ATE312605T1 (de) * 2002-06-29 2005-12-15 Aquanova Ger Solubilisate Tech Isoflavonkonzentrate sowie verfahren zu ihrer herstellung
DE20213787U1 (de) * 2002-09-04 2002-12-19 Warner Lambert Co Hautpflegemittel
DE10301631A1 (de) * 2003-01-17 2004-07-29 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Sojabohnenkeimextrakten in Kombination mit Vitamin C und/oder E sowie alpha-Glycosylrutin
US7718813B2 (en) 2003-08-15 2010-05-18 Nature Pure Labs Sw, Inc. Hydrolysis and purification of active plant compounds suitable for topical application
WO2007000192A1 (en) * 2005-06-29 2007-01-04 Dsm Ip Assets B.V. Topical compositions comprising nanoparticles of an isoflavone
US8951560B2 (en) * 2005-06-29 2015-02-10 Dsm Ip Assets B.V. Isoflavone nanoparticles and use thereof
US9345649B2 (en) 2006-12-21 2016-05-24 Avon Products, Inc. Cosmetic composition containing novel fractal particle-based gels
FR2915381B1 (fr) * 2007-04-27 2012-06-08 Vincience Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c
FR2915384B1 (fr) * 2007-04-27 2010-01-15 Vincience Utilisation d'un principe actif issu du soja (glycine maxl.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
FR2915378B1 (fr) * 2007-04-27 2009-08-21 Vincience Sa Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries
TWI411448B (zh) * 2007-12-27 2013-10-11 Avon Prod Inc 適合用於化妝品之光學模糊色素組合物
BR112012007841A2 (pt) * 2009-12-04 2016-03-15 Avon Prod Inc composições tópicas contendo derris scandens benth e um método de tratar a pele
IT1401364B1 (it) * 2010-07-09 2013-07-18 Rottapharm Spa Composizioni dermocosmetiche per protezione solare
US9623003B1 (en) 2013-04-04 2017-04-18 Humanetics Corporation Method of mitigating long and short term detrimental effects of exposure to medical imaging ionizing radiation by administration of genistein

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6061513A (ja) * 1983-09-14 1985-04-09 Sansho Seiyaku Kk 化粧料
JPS62201882A (ja) * 1985-11-18 1987-09-05 Yamanouchi Pharmaceut Co Ltd イソフラボン誘導体
JPH0784383B2 (ja) * 1991-07-23 1995-09-13 辻本化学工業株式会社 抗発癌プロモーター剤
US5545398A (en) * 1993-01-13 1996-08-13 Perricone; Nicholos V. Method and compositions for topical application to the skin of tocotrienol for prevention and/or treatment of skin damage
JP2605607B2 (ja) * 1993-12-08 1997-04-30 日本電気株式会社 半導体集積回路の故障解析装置
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
DE4432947C2 (de) * 1994-09-16 1998-04-09 New Standard Gmbh Mittel zur Behandlung der Haut und seine Verwendung

Also Published As

Publication number Publication date
CA2257579C (en) 2007-08-21
CA2257579A1 (en) 1997-12-11
WO1997046208A2 (en) 1997-12-11
EP0918504A2 (en) 1999-06-02
EP0918504B1 (en) 2003-03-19
US5824702A (en) 1998-10-20
ES2188963T3 (es) 2003-07-01
DE69719994D1 (de) 2003-04-24
AU716131B2 (en) 2000-02-17
DK0918504T3 (da) 2003-06-02
WO1997046208A3 (en) 1998-02-19
JP2000511907A (ja) 2000-09-12
AU3722597A (en) 1998-01-05
DE69719994T2 (de) 2003-09-04
ATE234599T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
PT918504E (pt) Utilizacao da genisteina como agente preventivo contra a fotolesao e o cancro cutaneos induzidos pela radiacao ultravioleta
MY106981A (en) Photoprotection compositions having reduced dermal irritation
ES2135674T3 (es) Composiciones cosmeticas antisolares y utilizaciones.
NO973900L (no) Nitrogenoksyd syntase inhibitor
MX2009003538A (es) Composiciones fotoprotectoras que comprenden combinacion sinergistica de compuestos activos de filtro solar.
GR3027749T3 (en) Cosmetic or pharmaceutical composition for topical application active against free radicals.
CA2411922A1 (en) Composition for pain mediation and apparatus and method of use thereof
MX9602782A (es) Composicion bloqueadora para el uso cosmetico o dermatologico, que contiene un agente formador de quelatos de hierro.
NZ242748A (en) Compositions containing a pseudocatalase for treating depigmentation disorders
IL129705A (en) Use of selected benzotriazole derivatives for protecting human and animal skin and hair from the harmful effects of uv radiation
MX9304117A (es) Agente cosmetico para el tratamiento de la piel, contra el envejecimiento provocado por los rayos ultravioleta y procedimiento para su obtencion.
DE69717495D1 (de) Verwendung eines terminalia catappa extraktes
MX9602880A (es) Uso de un agente antioxidante y/o antiradicales en una composicion bloqueadora o filtrante para uso cosmetico o dermatologico.
ATE99922T1 (de) Lichtschutzmittel mit verbesserter wirkung.
BR9508896A (pt) COmposição perfumada para o tratamento tópico da pele
ATE375163T1 (de) Zusammensetzungen enthaltend vernix und ein uv- schutzmittel, und deren verwendung
DK227090A (da) Organisk guldkompleks til topisk anvendelse
BR0009860A (pt) Composições cosméticas de uso tópico que contém um derivado de benzotriazol e um bis-resorcinol triazina, uso das mesmas e processo de tratamento cosmético
BR9805928A (pt) Composição cosmética ou farmacêutica e processos paraa proteger as células da pele de pano por uv, e para evitar o fotoenvelhicemento.
MXPA05003081A (es) Uso de extracto de photomorphe umbellata composicion a base de extracto de photomorphe umbellata y metodo de aplicacion del extracto de photomorphe umbellata.
BR9202455A (pt) Composicao cosmetica para protecao contra aexposicao ao sol,e,tratamento topico da pele para protege-la
YU75002A (sh) Lokalna antioksidantna vitaminska smeša za negu kože
JPS55122708A (en) Hair treatment for preventing poliosis
TH9147EX (th) ส่วนประกอบสารป้องกันแสงแดด